Bai Yaowei相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects

肽类作为癌症免疫疗法中的多功能调节剂：最新进展、挑战与未来展望

期刊:Pharmaceutics

影响因子:5.5

doi:10.3390/pharmaceutics17010046

Lei, Yu; Liu, Jiacheng; Bai, Yaowei; Zheng, Chuansheng; Wang, Dongyuan

免疫/内分泌

发表日期：2025

文献求助收藏

Atezolizumab Plus Bevacizumab Combined with or without Transarterial Chemoembolization in the Treatment of Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Study

阿特珠单抗联合贝伐珠单抗，加或不加经动脉化疗栓塞术治疗晚期肝细胞癌：一项单中心回顾性研究

期刊:Journal of Hepatocellular Carcinoma

影响因子:3.4

doi:10.2147/JHC.S515453

Li, Jing; Bai, Yaowei; Xiong, Fu; Liu, Xiaocui; Hu, Junwen; Zhang, Guilin; Liu, Jiayun; Wu, Suyue; Zheng, Chuansheng; Kan, Xuefeng

细胞生物学

发表日期：2025

文献求助收藏

CT-Based Radiomics-Clinical Model for Predicting Recurrence in VETC-Positive HCC Patients After Hepatectomy

基于CT的放射组学-临床模型预测VETC阳性肝细胞癌患者肝切除术后复发

期刊:Journal of Hepatocellular Carcinoma

影响因子:3.4

doi:10.2147/JHC.S549825

Lei, Yu; Bai, Yaowei; Su, Yang; Bai, Xiatong; Wang, Yingliang; Zheng, Chuansheng

细胞生物学

发表日期：2025

文献求助收藏

TACE Empowers Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors in Unresectable HCC: A Multicenter Retrospective Study

TACE增强免疫检查点抑制剂和酪氨酸激酶抑制剂在不可切除肝细胞癌中的疗效：一项多中心回顾性研究

期刊:Journal of Cancer

影响因子:3.2

doi:10.7150/jca.112706

Lei, Yu; Bai, Yaowei; Bai, Xiatong; Liu, Jiacheng; Sun, Bo; Wu, Wenlong; Zhi, Xiaoling; Su, Yang; Zhang, Hongsen; Zheng, Chuansheng

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Long-term radiological and pulmonary function abnormalities at 3 years after COVID-19 hospitalisation: a longitudinal cohort study

新冠肺炎住院治疗3年后长期放射学和肺功能异常：一项纵向队列研究

期刊:European Respiratory Journal

影响因子:21

doi:10.1183/13993003.01612-2023

Han, Xiaoyu; Chen, Lu; Guo, Liyan; Wu, Linxia; Alwalid, Osamah; Liu, Jie; Zheng, Yuting; Chen, Leqing; Wu, Wenlong; Li, Hanting; Luo, Qinyue; Zhao, Huangxuan; Zhang, Lijie; Bai, Yaowei; Sun, Bo; Sun, Tao; Gui, Yuxi; Nie, Tong; Chen, Lei; Yang, Fan; Fan, Yanqing; Shi, Heshui; Zheng, Chuansheng

发表日期：2024

文献求助收藏

Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography

用于超高分辨率磁共振血管造影的非晶态白蛋白钆基纳米颗粒

期刊:ACS Applied Materials & Interfaces

影响因子:8.2

doi:10.1021/acsami.3c16391

Liu, Chenchen; Liu, Xiaoming; Wei, Zhihao; Chang, Zong; Bai, Yaowei; Zeng, Pei; Cao, Qi; Tie, Changjun; Lei, Ziqiao; Sun, Peng; Liang, Huageng; Sun, Qinchao; Zhang, Xiaoping

发表日期：2024

文献求助收藏

Synergistic Effects of Nanoscale CaO(2) Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination

纳米级氧化钙(2)与PD-1抑制剂联合治疗肝细胞癌的协同效应：一种有前景的组合疗法

期刊:International Journal of Nanomedicine

影响因子:6.5

doi:10.2147/IJN.S440387

Wang, Yingliang; Ju, Shuguang; Zhou, Huimin; Bai, Yaowei; Zhou, Chen; Liu, Jiacheng; Dong, Xiangjun; Zheng, Chuansheng

细胞生物学

发表日期：2024

文献求助收藏

Comparison of specialized stent versus generic stent and bare stent combination for transjugular intrahepatic portosystemic shunt creation

经颈静脉肝内门体分流术中专用支架与通用支架及裸支架组合的比较

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-024-64358-0

Bai, Yaowei; Liu, Jiacheng; Wang, Chaoyang; Yao, Wei; Ju, Shuguang; Wang, Yingliang; Zhou, Chen; Dong, Xiangjun; Zheng, Chuansheng

发表日期：2024

文献求助收藏

Enhanced efficacy of combined VEGFR peptide-drug conjugate and anti-PD-1 antibody in treating hepatocellular carcinoma

联合使用VEGFR肽-药物偶联物和抗PD-1抗体可增强治疗肝细胞癌的疗效

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-024-72907-w

Liu, Jiacheng; Bai, Yaowei; Liu, Xiaoming; Zhou, Binqian; Sun, Peng; Wang, Yingliang; Ju, Shuguang; Zhou, Chen; Wang, Chaoyang; Yao, Wei; Yang, Huihui; Jiang, Xin; Yang, Lian; Wang, Dongyuan; Zheng, Chuansheng

细胞生物学

发表日期：2024

文献求助收藏

The time window for pre-emptive transjugular intrahepatic portosystemic shunt could be extended to 5 days

预防性经颈静脉肝内门体分流术的时间窗口可以延长至5天。

影响因子:3.6

doi:10.1016/j.heliyon.2024.e25824

Dong, Xiangjun; Liu, Jiacheng; Bai, Yaowei; Liu, Xiaoming; Ma, Jinqiang; Zhou, Binqian; Ren, Yanqiao; Zheng, Chuansheng

发表日期：2024

文献求助收藏